v3.25.2
Condensed Consolidated Statements of Cash Flows - EUR (€)
€ in Millions
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Statement of cash flows [abstract]      
CASH FLOWS FROM OPERATING ACTIVITIES € 2,604 € (60,172)  
Profit/(loss) for the period 7,463 6,592  
Adjustments made to obtain the cash flows from operating activities 17,400 13,925  
Depreciation and amortisation cost 1,626 1,656  
Other adjustments 15,774 12,269  
Net increase/(decrease) in operating assets 33,806 82,440  
Financial assets held-for-trading 9,104 35,042  
Non-trading financial assets mandatorily at fair value through profit or loss (398) 402  
Financial assets at fair value through profit or loss 882 (592)  
Financial assets at fair value through other comprehensive income (6,706) 1,295  
Financial assets at amortised cost 29,804 45,626  
Other operating assets 1,120 667  
Net increase/(decrease) in operating liabilities 12,664 3,232  
Financial liabilities held-for-trading 5,777 13,709  
Financial liabilities designated at fair value through profit or loss (817) (5,968)  
Financial liabilities at amortised cost 7,039 (1,103)  
Other operating liabilities 665 (3,406)  
Income tax recovered/(paid) (1,117) (1,481)  
CASH FLOWS FROM INVESTING ACTIVITIES (563) (2,301)  
Payments 4,247 6,034  
Tangible assets 3,202 4,738  
Intangible assets 812 909  
Investments 46 362  
Subsidiaries and other business units 187 25  
Non-current assets held for sale and associated liabilities 0 0  
Other payments related to investing activities 0 0  
Proceeds 3,684 3,733  
Tangible assets 2,927 2,991  
Intangible assets 0 0  
Investments 275 294  
Subsidiaries and other business units 53 4  
Non-current assets held for sale and associated liabilities 429 444  
Other proceeds related to investing activities 0 0  
CASH FLOWS FROM FINANCING ACTIVITIES (8,058) (4,173)  
Payments 8,936 8,587  
Dividends 1,643 1,485  
Subordinated liabilities 4,084 3,210  
Redemption of own equity instruments 0 0  
Acquisition of own equity instruments 2,021 2,159  
Other payments related to financing activities 1,188 1,733  
Proceeds 878 4,414  
Subordinated liabilities 306 3,908  
Issuance of own equity instruments 0 0  
Disposal of own equity instruments 542 471  
Other proceeds related to financing activities 30 35  
EFFECT OF FOREIGN EXCHANGE RATE DIFFERENCES (8,185) 2,538  
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS (14,202) (64,108)  
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 192,208 220,342 € 220,342
CASH AND CASH EQUIVALENTS AT END OF PERIOD 178,006 156,234 192,208
COMPONENTS OF CASH AND CASH EQUIVALENTS AT END OF PERIOD      
Cash 6,807 7,113  
Cash equivalents at central banks 158,978 134,228  
Other financial assets 9,770 14,893  
Less: Bank overdrafts refundable on demand 0 0  
TOTAL CASH AND CASH EQUIVALENTS AT END OF PERIOD 175,555 156,234 € 192,208
In which: restricted cash 0  
TOTAL CASH AND CASH EQUIVALENTS AT END OF PERIOD ASSOCIATED WITH NON-CURRENT ASSETS HELD FOR SALE € 2,451 € 0